Title
Clinical Trial to Evaluate the Tolerability and Efficacy of Microencapsulated Calcium Carbonate
Clinical Trial to Evaluate the Gastric Tolerability and Efficacy of the Food Supplement of Microencapsulated Calcium Carbonate vs Conventional Calcium Carbonate and Calcium Citrate
Phase
Phase 3Lead Sponsor
Instituto PalaciosStudy Type
InterventionalStatus
Completed No Results PostedIndication/Condition
Hypocalcemia; DietaryIntervention/Treatment
Calcium supplementStudy Participants
208Interventional Clinical trial with food supplement, randomized, double-blind, comparative between microencapsulated calcium, calcium carbonate salts standardized and calcium citrate, in a population of postmenopausal women, lasting 1 month.
Calcium supplement for low contribution of elemental calcium in the daily diet
Microencapsulated calcium, 1389 mg orally (10% protein and 90% calcium carbonate, corresponding to 500 mg of calcium element per tablet). There will be 2 doses of 1389 mg each orally, to make a total contribution of 1,000 mg. of calcium element.
Microencapsulated calcium1316 mg orally (5% protein and 95% calcium carbonate, corresponding to 500 mg of calcium element per tablet). There will be 2 shots of 1,316 mg each orally, to make a total contribution of 1,000 mg. calcium element
1,250 mg orally (500 mg of calcium element). There will be 2 doses of 1,250 mg. each orally, to make a total contribution of 1,000 mg. of calcium element.
1,500 mg orally (315 mg of calcium element). There will be 2 taken orally, to make a total contribution of 945 mg. calcium element
Inclusion Criteria: Postmenopausal woman Low contribution of elemental calcium in the daily diet Exclusion Criteria: Hypersensitivity to the active substances or to any of the excipients Renal insufficiency History of kidney or urinary stones Use in the last month of diuretics (furosemide, ethacrynic acid), aluminum salts and / or thyroid hormones Use of any other drug or experimental device during the 30 days prior to the selection